COPENHAGEN (Reuters) -Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles ...

This episode features Anthony J. Colistra, President of MD Live by Evernorth, discussing how virtual care has evolved, where consumer demand is headed, and how MD Live is using AI to personalize ...

Danish pharmaceutical giant Novo Nordisk on Tuesday named its new CEO and cut its full-year sales and profit guidance.

Wegovy prescriptions jumped 33%, but experts say Novo Nordisk must prove its growth is sustainable beyond the ban on rivals ...

These Wegovy and Ozempic lawsuits claim that drug companies failed to adequately warn users of the risk of NAION, vision loss, and blindness, despite emerging evidence and patient complaints.

Viatris’ generic to Wegovy has yet to secure FDA approval. Branded Wegovy, for its part, could lose U.S. patent protection in 2032, according to Novo’s 2024 annual report (PDF).

Learn about safely stopping Wegovy (semaglutide), what effects it may have on your body, and ways to keep the weight off after stopping treatment.

Congress revives fight for coverage for Wegovy and other weight-loss drugs The Treat and Reduce Obesity Act bill could also ramp up federal support for obesity research efforts.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging.

Learn about what foods to eat while you're using Wegovy and what foods to avoid to maximize weight loss or manage your weight.